Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14378860 | 0.89 | DGKA (0.46) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL26616563 | 0.84 | DGKA (0.44) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL13978973 | 0.82 | DGKA (0.50) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL29028337 | 0.81 | ADRA2A (0.46) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL813361 | 0.80 | ADRA2A (0.54) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL13871663 | 0.80 | DGKA (0.39) | DGKAMAPTTSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL13695952 | 0.80 | LTA4H (0.37) | DGKATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL960158 | 0.79 | CYP1A2 (0.47) | TSHRALDH1A1SMN1; SMN2GAA | |
| SCHEMBL12285157 | 0.79 | DGKA (0.37) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL26616596 | 0.78 | ADRA2A (0.33) | DGKAADRA2AADRA1AMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080097017-A2 | Organic Silicon Compound, Hydrophilic Composition Containing The Same and Hydrophilic Member | FUJIFILM CORPORATION (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080097017-A2 | Organic Silicon Compound, Hydrophilic Composition Containing The Same and Hydrophilic Member | ORC3, OR10J3, H1-3 | DGKA 4811/4885ADRA2A 3801/4885ADRA1A 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.